Comorbidities in the preindex and postindex periods
| Preindex | Postindex | |||
| Commercial/ Medicare (n=11 325) | Medicaid (n=5164) | Commercial/ Medicare (n=11 325) | Medicaid (n=5164) | |
| Deyo-Charlson Comorbidity Index, mean (SD) | 0.46 (1.05) | 0.66 (1.25) | 0.54 (1.16) | 0.81 (1.44) |
| Comorbid c ondition, n (%) * | ||||
| Cellulitis | 3865 (34.1) | 2427 (47.0) | 3929 (34.7) | 2732 (52.9) |
| Psychiatric disorder | 2747 (24.3) | 2696 (52.2) | 3342 (29.5) | 3043 (58.9) |
| Hypertension | 2548 (22.5) | 1232 (23.9) | 3009 (26.6) | 1485 (28.8) |
| Obesity | 1210 (10.7) | 1246 (24.1) | 1870 (16.5) | 1604 (31.1) |
| Mood disorders | 1267 (11.2) | 1401 (27.1) | 1485 (13.1) | 1637 (31.7) |
| Dyslipidemia | 1668 (14.7) | 671 (13.0) | 2013 (17.8) | 832 (16.1) |
| Diabetes mellitus type 2 | 1389 (12.3) | 719 (13.9) | 1590 (14.0) | 849 (16.4) |
| Anxiety disorders | 1001 (8.8) | 921 (17.8) | 1263 (11.2) | 1105 (21.4) |
| Acne | 1024 (9.0) | 342 (6.6) | 1509 (13.3) | 558 (10.8) |
| Sleep disorders | 993 (8.8) | 568 (11.0) | 1210 (10.7) | 711 (13.8) |
| Arthropathies | 979 (8.6) | 536 (10.4) | 1180 (10.4) | 625 (12.1) |
| Cardiovascular disease | 1011 (8.9) | 483 (9.4) | 1234 (10.9) | 548 (10.6) |
| Iron deficiency anaemia | 660 (5.8) | 478 (9.3) | 880 (7.8) | 625 (12.1) |
| Depression | 670 (5.9) | 622 (12.0) | 766 (6.8) | 681 (13.2) |
| Thyroid disease | 765 (6.8) | 330 (6.4) | 950 (8.4) | 371 (7.2) |
| Hypothyroidism | 544 (4.8) | 255 (4.9) | 701 (6.2) | 290 (5.6) |
| Substance abuse disorders | ||||
| Drug dependence | 79 (0.7) | 371 (7.2) | 117 (1.0) | 403 (7.8) |
| Alcohol dependence | 84 (0.7) | 135 (2.6) | 112 (1.0) | 149 (2.9) |
| Solid tumour without metastasis | 297 (2.6) | 66 (1.3) | 355 (3.1) | 102 (2.0) |
| Diabetes mellitus type 1 | 219 (1.9) | 169 (3.3) | 236 (2.1) | 202 (3.9) |
| Pilonidal cyst | 214 (1.9) | 92 (1.8) | 225 (2.0) | 137 (2.7) |
| Polycystic ovarian disease | 185 (1.6) | 84 (1.6) | 247 (2.2) | 109 (2.1) |
| Crohn disease/ulcerative colitis | 207 (1.8) | 53 (1.0) | 225 (2.0) | 54 (1.0) |
| Down syndrome | 46 (0.4) | 107 (2.1) | 56 (0.5) | 112 (2.2) |
| Lymphoma | 23 (0.2) | 8 (0.2) | 31 (0.3) | 9 (0.2) |
| Squamous cell carcinoma | 4 (<0.1) | 1 (<0.1) | 12 (0.1) | 6 (0.1) |
*Sorted by decreasing frequency in the postindex period (Commercial/Medicare and Medicaid populations combined).